||20% of survey complete.|
"The practice of advertising has clearly been revolutionized by the emergence of the Internet. Today, we can match the content of an ad to the interests of the consumer in ways undreamed of just a few short years ago," said Nancy Hill, President & CEO, 4A's.
One way of matching content of ads to the interests of the consumer is by using Behavioral Targeting (BT) techniques. BT (aka interest-based advertising) uses information collected on an individual's web-browsing behavior, such as the pages they have visited or the searches they have made, to select which advertisements to display to that individual. Practitioners believe this helps them deliver their online advertisements to the users who are most likely to be interested.
To implement BT, users are tracked using invisible cookies stored on their computers. That is the only way that site D can know a visitor to the site previously visited sites A, B, and C. Site D can then use this information to serve the appropriate ads or other content based on previous visits.
"Ethical issues exist for technologies such as behavioral targeting," said R.J. Lewis, President and CEO e-Healthcare Solutions, Inc. "No one wants to be 'followed' around the Web with a human immunodeficiency virus (HIV) ad, simply because they have previously visited a website with HIV-related content. However, health food or gym equipment can be promoted to those who have viewed fitness content or such benign disease categories as allergies or gastroesophageal reflux disease. Behavioral targeting creates a problem with regard to acceptable practices and defining what health care categories may be appropriate for employing behavioral-targeting technologies."
Please take a few minutes to tell us YOUR opinion about whether or not pharmaceutical marketers should use behavioral targeted advertising and, if so, what restrictions or guidelines should be applied.
Background on this issue can be found on Pharma Marketing Blog. See this this post and then return to the survey.
After you complete the survey, you will be able to see an up-to-date summary of results. No comments or other identifying information is included in the summary.
ALSO, at the end of the survey, you will be able to download the Pharma Marketing News article "Use of Behavioral Targeting by Pharma Marketers."
Your comments are confidential (anonymous) unless you specifically provide your contact information at the end of the survey and allow us to attribute comments to you personally.
Click on the "Next" button below to continue.